These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 17366349

  • 21. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF, Vickar EL.
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J, Jakob J, Bender HJ, Hewer W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y, Gibel A, Yorkov V, Ritsner MS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1401-9. PubMed ID: 17669574
    [Abstract] [Full Text] [Related]

  • 25. Neuroleptic malignant syndrome: observations on altered consciousness.
    Deuschl G, Oepen G, Hermle L, Kindt H.
    Pharmacopsychiatry; 1987 Jul 01; 20(4):168-70. PubMed ID: 3615574
    [Abstract] [Full Text] [Related]

  • 26. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL, Su TP, Chou YH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul 01; 30(5):963-4. PubMed ID: 16624468
    [Abstract] [Full Text] [Related]

  • 27. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A, Velikonja I.
    Hum Psychopharmacol; 2003 Jun 01; 18(4):301-9. PubMed ID: 12766935
    [Abstract] [Full Text] [Related]

  • 28. Acute dystonia, akathisia, and parkinsonism induced by ziprasidone.
    Praharaj SK, Jana AK, Sarkhel S, Sinha VK.
    Am J Ther; 2014 Jun 01; 21(2):e38-40. PubMed ID: 23698184
    [Abstract] [Full Text] [Related]

  • 29. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M, Savas HA, Selek S, Savas E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun 01; 30(4):745-7. PubMed ID: 16580766
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neuroleptic malignant syndrome and clozapine monotherapy.
    Chatterton R, Cardy S, Schramm TM.
    Aust N Z J Psychiatry; 1996 Oct 01; 30(5):692-3. PubMed ID: 8902179
    [Abstract] [Full Text] [Related]

  • 32. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K, Warchala A.
    Wiad Lek; 2005 Oct 01; 58(9-10):572-4. PubMed ID: 16529073
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE, Ernest D.
    Crit Care Resusc; 2007 Dec 01; 9(4):338-40. PubMed ID: 18052897
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F, Risse A.
    Fortschr Neurol Psychiatr; 1986 Dec 01; 54(12):398-401. PubMed ID: 2880787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.